Literature DB >> 22052633

Nodal anaplastic large-cell lymphoma ALK-1- with CD30+ cutaneous lymphoproliferation treated with mistletoe: spontaneous remission or treatment response?

G Kameda1, W Kempf, I Oschlies, K Michael, G Seifert, A Längler.   

Abstract

A 12-year old girl presented with general weakness and weight loss, a localised cervical lymph node enlargement and cutaneous lesions compatible with lymphomatoid papulosis (LyP). Biopsies from lymph node and skin revealed a histological diagnosis of nodal large cell ALK-1- anaplastic lymphoma (ALCL) with a synchronous CD30+ cutaneous lymphoproliferation consistent with lymphomatoid papulosis (LyP). The girl was treated with mistletoe (MT) as monotherapy. Within 1 week after initiation of MT-treatment the skin lesions and lymph node enlargement improved. Under continuing MT-therapy 30 months after diagnosis the patient is still in complete remission. It is not possible to know whether this was a rare case of spontaneous remission of the nodal and skin-manifestations of this CD30+ T-cell lymphoproliferation or whether the observed effect was a specific therapeutic response to MT-treatment. © George Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22052633     DOI: 10.1055/s-0031-1285914

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  3 in total

1.  Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up.

Authors:  Georg Seifert; Sarah B Blakeslee; Gabriele Calaminus; Farid I Kandil; Andrea Barth; Toralf Bernig; Carl Friedrich Classen; Selim Corbacioglu; Jürgen Föll; Sven Gottschling; Bernd Gruhn; Claudia Vom Hoff-Heise; Holger N Lode; David Martin; Michaela Nathrath; Felix Neunhoeffer; Arnulf Pekrun; Beate Wulff; Tycho Zuzak; Günter Henze; Alfred Längler
Journal:  BMC Cancer       Date:  2022-06-13       Impact factor: 4.638

2.  Emerging roles of mistletoes in malignancy management.

Authors:  Seema Patel; Suryakanta Panda
Journal:  3 Biotech       Date:  2013-03-07       Impact factor: 2.406

3.  Durable Regression of Primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe Treatment: Two Case Reports.

Authors:  Maurice Orange; Aija Lace; Maria P Fonseca; Broder H von Laue; Stefan Geider; Gunver S Kienle
Journal:  Glob Adv Health Med       Date:  2012-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.